BLLN

12.03% -12.25

Handel nachbörslich: 89.75 0.20 +0.22%

Billiontoone Inc (BLLN)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Billiontoone Inc Stock (BLLN) Company Profile

Billiontoone Inc

Healthcare (1103)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

BLLN's Discussions on Twitter

Vergleichen Sie BLLN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BLLN Billiontoone Inc	89.55	4.62B	0	0	0	0.00
TMO Thermo Fisher Scientific Inc	580.13	220.92B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	221.20	154.97B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	701.48	56.98B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	146.89	42.96B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	223.55	37.62B	15.90B	1.28B	2.21B	7.2842

Billiontoone Inc Aktie (BLLN) Neueste Nachrichten

Finanzdaten der Billiontoone Inc-Aktie (BLLN)

Es liegen keine Finanzdaten für Billiontoone Inc (BLLN) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Billiontoone Inc (BLLN)

Billiontoone Inc Stock (BLLN) Company Profile

Vergleichen Sie BLLN mit anderen Aktien

Billiontoone Inc Aktie (BLLN) Neueste Nachrichten

BillionToOne SVP Johnson buys $414k in class A common stock By Investing.com - Investing.com South Africa

BillionToOne SVP Johnson buys $414k in class A common stock - Investing.com Australia

BillionToOne Insiders Make Bold Moves with Major Stock Purchases! - TipRanks

Rai Akshay buys billionToOne shares worth $150,000 By Investing.com - Investing.com UK

Rai Akshay buys billionToOne shares worth $150,000 - Investing.com

BillionToOne, Inc. Completes Successful IPO Raising $314 Million - The Globe and Mail

BillionToOne director Bremner buys $2.5 million in shares By Investing.com - Investing.com UK

BillionToOne director Bremner buys $2.5 million in shares - Investing.com

BillionToOne Transaction - William Blair

BillionToOne (BLLN): Reviewing the High Valuation After Recent Share Price Dip - Yahoo Finance

Evommune and BillionToOne climb on trading debut - MSN

BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times

BillionToOne, Inc. Closes Upsized Initial Public Offering Raising $314 Million on Nasdaq - Quiver Quantitative

BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut - WKZO

BillionToOne: A Deserved Opening Day Boom (NASDAQ:BLLN) - Seeking Alpha

Pair Of Health-Focused Startups Net $423M In Combined IPOs - Law360

BillionToOne raises $273.1 million in upsized IPO By Investing.com - Investing.com Nigeria

BillionToOne, Inc. (BLLN): Precision Diagnostics Firm Soars 82% in One of 2025’s Best IPO Debuts - Smartkarma

BillionToOne, Evommune Shares Climb in IPOs - The Wall Street Journal

How A Turkish Immigrant Engineered A Successful Diagnostics Startup IPO - Forbes

BillionToOne raises $273.1 million in upsized IPO - Investing.com India

BillionToOne shares rise on first day of trading - Axios

Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering - PR Newswire

BillionToOne (BLLN.US) went public on Nasdaq, surging 81.57% on its first day, with its market value rising to nearly USD 4.8 billion. - 富途牛牛

BillionToOne Shares Surge 82% After Upsized $273 Million IPO - Bloomberg.com

BillionToOne IPO becomes $5 billion explosion as Bay Area medical test maker's stock soars in debut - The Business Journals

Evommune and BillionToOne climb on trading debut (EVMN:NYSE) - Seeking Alpha

BillionToOne Shares Surge Following Firm's $273M IPO - GenomeWeb

BillionToOne shares soar 67% in Nasdaq debut, valuing firm at $4.4 billion - Investing.com Canada

BillionToOne raises $273.1m in IPO - Yahoo Finance

BillionToOne poised to open 66.7% above offer price in Nasdaq debut - TradingView

BillionToOne indicating open above $91, upsized IPO priced at $60 By Investing.com - Investing.com Philippines

Billiontoone shares surge after $273M upsized IPO - BioWorld MedTech

Evommune, BillionToOne set IPO price - MSN

Evommune and BillionToOne set IPO prices (EVMN:NYSE) - Seeking Alpha

Drug developer Evommune targets $150 million in IPO amid government shutdown - The Business Journals

BillionToOne raises $273M in IPO - Axios

BillionToOne prices upsized IPO at $60 per share, raising $273.1 million - Investing.com Philippines

BillionToOne Prices Upsized IPO at $60 Per Share on Nasdaq - parameter.io

Molecular diagnostics firm BillionToOne raises $273 million in US IPO - MSN

BLLN IPO NewsMolecular diagnostics company BillionToOne prices upsized IPO at $60, above the range - renaissancecapital.com

BillionToOne Prices IPO At $60 Per Share - RTTNews

BillionToOne prices upsized IPO at $60 per share By Investing.com - Investing.com Philippines

Molecular Diagnosis Firm BillionToOne Raises $273 Million in IPO - Bloomberg.com

BillionToOne prices upsized IPO at $60 per share - Investing.com India

Finanzdaten der Billiontoone Inc-Aktie (BLLN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie BLLN